Literature DB >> 2424024

Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

A De Rossi, G Franchini, A Aldovini, A Del Mistro, L Chieco-Bianchi, R C Gallo, F Wong-Staal.   

Abstract

We isolated six human T-cell lymphotropic virus type I (HTLV-I)-transformed T-cell clones carrying the phenotypic markers of helper and suppressor T cells. Five of the transformed T-cell clones produced infectious HTLV-I, but one (clone 55) contained a defective provirus and was therefore not competent for viral replication. To test whether there is interference between HTLV-I and the cytopathic virus HTLV-III in infection and/or their biological effects, we superinfected these T-cell clones with HTLV-III. The recipient cells that we used displayed either the OKT4 or the OKT8 membrane antigens (helper or suppressor phenotype, respectively). The superinfection was successful in all cases, regardless of phenotype of the recipient cells and status of viral production. Both HTLV-III and HTLV-I were expressed by the infected cell lines containing complete HTLV-I proviruses, as demonstrated by electron microscopy and immunofluorescence. However, only HTLV-III in the virus mixture obtained from the culture supernatants was transmitted to the human neoplastic T-cell line H9. The nonproducer clone 55 did not express HTLV-I upon superinfection with HTLV-III. HTLV-III exerted its cytopathic effect on all but one of the superinfected T-cell clones 15-20 days after infection. The exception, clone 67, is also the only cell clone that expresses the phenotypic marker of suppressor T lymphocytes (OKT8); the other clones carry the OKT4 antigen, correlated with helper functions. The virus released from the superinfected clone 67 is cytopathic for fresh peripheral and umbilical-cord blood lymphocytes, suggesting that cellular factors, rather than a genetic change in the virus, may be responsible for the lack of cytopathic effect of HTLV-III on the suppressor T-cell clone 67.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424024      PMCID: PMC323719          DOI: 10.1073/pnas.83.12.4297

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  A new HTLV-III/LAV encoded antigen detected by antibodies from AIDS patients.

Authors:  J S Allan; J E Coligan; T H Lee; M F McLane; P J Kanki; J E Groopman; M Essex
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

2.  Efficient transfer of large DNA fragments from agarose gels to diazobenzyloxymethyl-paper and rapid hybridization by using dextran sulfate.

Authors:  G M Wahl; M Stern; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

3.  Isolation of a new type C retrovirus (HTLV) in primary uncultured cells of a patient with Sézary T-cell leukaemia.

Authors:  B J Poiesz; F W Ruscetti; M S Reitz; V S Kalyanaraman; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

4.  Transformation of normal human cord lymphocytes by co-cultivation with a lethally irradiated human T-cell line carrying type C virus particles.

Authors:  I Miyoshi; S Yoshimoto; I Kubonishi; H Taguchi; Y Shiraishi; Y Ohtsuki; T Akagi
Journal:  Gan       Date:  1981-12

5.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma.

Authors:  S P Staal; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

6.  Ultrastructural comparison of a virus from a Rhesus-monkey mammary carcinoma with four oncogenic RNA viruses.

Authors:  B Kramarsky; N H Sarkar; D H Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1971-07       Impact factor: 11.205

7.  Correlation between cell killing and massive second-round superinfection by members of some subgroups of avian leukosis virus.

Authors:  S K Weller; A E Joy; H M Temin
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

8.  Biochemical and immunological properties of the DNA polymerase and RNAase H activities of purified feline leukemia virus reverse transcriptase.

Authors:  H M Rho; R C Gallo
Journal:  Cancer Lett       Date:  1980-09       Impact factor: 8.679

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.

Authors:  M Robert-Guroff; F W Ruscetti; L E Posner; B J Poiesz; R C Gallo
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  22 in total

1.  RNAs from genetically distinct retroviruses can copackage and exchange genetic information in vivo.

Authors:  P D Yin; W S Hu
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Heterogeneity of the ARV-2 strain and natural isolates of the human immunodeficiency virus.

Authors:  A F Etkin; M I Bukrinsky
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

3.  Cytopathic effect of human immunodeficiency virus in T4 cells is linked to the last stage of virus infection.

Authors:  R Leonard; D Zagury; I Desportes; J Bernard; J F Zagury; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

4.  Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1.

Authors:  J Cao; I W Park; A Cooper; J Sodroski
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses.

Authors:  P Lusso; F Lori; R C Gallo
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

6.  Intracellular distribution of the envelope glycoprotein of human immunodeficiency virus and its role in the production of cytopathic effect in CD4+ and CD4- human cell lines.

Authors:  Y Koga; M Sasaki; K Nakamura; G Kimura; K Nomoto
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.

Authors:  N Manca; A Caruso; C Bonfanti; E Savoldi; R Li Vigni; F Pirali; P L Sapelli; A Turano
Journal:  Eur J Epidemiol       Date:  1989-03       Impact factor: 8.082

8.  Dissociation of unintegrated viral DNA accumulation from single-cell lysis induced by human immunodeficiency virus type 1.

Authors:  L Bergeron; J Sodroski
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes.

Authors:  L Mercure; D Phaneuf; M A Wainberg
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 10.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.